Pituitary Neuroendocrine Tumor Diagnosis

Multimodal Model for Non-Invasive Detection of DRD2, SSTR2 and ESR1 Receptor Profiling in Pituitary Neuroendocrine Tumors: A Retrospective Study
Estimating diagnostic delay in patients with pituitary adenomas in Sweden: a cross-sectional study
Baseline testosterone levels as a predictor of hypogonadism resolution in male patients with isolated hyperprolactinemia
Secondary Pituitary Abscess Inside a Macroadenoma Complicated by Postoperative Hemorrhage and Reinfection: A Case Report
Serums miR-24-3p and miR-1301-3p as Potential Biomarkers in MEN1 Syndrome
Revised European Society of Endocrinology Clinical Practice Guideline for the management of aggressive pituitary tumours and pituitary carcinomas
Revisiting Late-Onset Bipolar Disorder Associated With Pituitary Adenoma: A Cross-Sectional, Multidisciplinary, Case-Based Analysis
Pituitary and pineal gland metastases from pulmonary neuroendocrine carcinoma: A case report and literature review

Positron emission tomography/CT may be useful to detect tumors in patients with equivocal MRI results.

11C methionine positron emission tomography PET/CT can provide valuable diagnostic information when F-FDG PET/CT yields negative results, especially in patients with recurrent microadenomas ¹⁾.

Endocrine screening.

Magnetic resonance imaging for pituitary neuroendocrine tumor diagnosis.

see Pituitary microadenoma diagnosis

see Pituitary macroadenoma diagnosis

¹⁾

Feng Z, He D, Mao Z, Wang Z, Zhu Y, Zhang X, Wang H. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning pituitary neuroendocrine tumors. Clin Nucl Med. 2016 Mar;41(3):e130-4. doi: 10.1097/RLU.0000000000001085. PubMed PMID: 26646998.